Conclusion Short-lasting oxytocin inhibition through the OT-receptor antagonist atosiban did not significantly increase the incidence of migraine attacks in women with episodic migraine, although a numerical trend was observed
Participants receiving glutathione rather than a saline solution placebo were given intravenous infusions two times daily for five days, and then analyzed for mobility
Hydrogen-releasing tablets are suitable for anyone who wants to meaningfully supplement their daily diet and support their body in terms of cell health, regeneration, and vitality
by Sarah Muntel, RD Spring 2026 Nutritional needs change throughout life, from childhood to adolescence and into Read Article by Audrey Wells, MD Spring 2026 Obstructive sleep apnea (OSA) and obesity often occur in the same Read Article Your Support Fuels Education Your donation helps OAC create high-quality education that supports real people on their health journeys
We're confident you'll see results, but if you don't, we want you to have your money back
